Overview
SINOMAB BIO-B (3681)
SinoMab BioScience Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatm...
- Open
- 0.955
- High
- 1.000
- Low
- 0.955
- Prev. Close
- 0.955
- Volume
- 461.70K
- Turnover
- 449.18K
- Avg Price
- 0.973
- Bid/Ask Ratio
- -89.33%
- Amplitude
- 4.71%
- 52wk High
- 2.190
- Volume Ratio
- 0.39
- Turnover Ratio
- 0.03%
- 52wk Low
- 0.955
- HK Mkt Cap
- 1.33B
- Market CapHKD
- 1.33B
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -0.152
- EPSDynamic
- -0.212
- EPSStatic
- --
- BVPS
- 0.30
- P/B
- 3.20
- HK Shares
- 1.39B
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 1.39B
- Min lot size
- 300
- Currency
- HKD
SINOMAB BIO-B Analyst Rating
View moreForecast & Rating
Jul 21, 2020- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 1
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
Daily Events
- Jul, 3
SinoMab Bioscience staged a strong rebound today, surging 20.4% to close at HKD 1.300, with an intraday range of 23.1% from HKD 1.080 to HKD 1.330. The rally was driven by multiple recent positive developments: an annual loss narrowing 43.3% YoY to RMB 105 million, first cohort dosing completion for SM17 subcutaneous injection in China, and China IND approval to expand SM17 into inflammatory bowel disease. In Q4, EPS loss narrowed 51.7% YoY to HKD 0.0226, and net loss shrank 39.0% YoY. The stock closed above its MA20 (HKD 1.129) but remains 65.4% below the 52-week high of HKD 3.76, with a YTD decline of 6.5% and PB of 3.2x. However, the MA60 at HKD 1.341 still sits above the current price, suggesting the recovery remains incomplete.
News
Market Movers · Sinomab Bio hits 52-week low
Tip Ranks · SinoMab Completes Disposal of Suzhou Property and Facility
Market Movers · Sinomab Bio falls 6% in Hong Kong trading
Global Report · Hong Kong's junk-drawer stocks are all rebranding. Good luck with that.
Global Report · A Takeover, a Profit Warning, and Hong Kong's Forgotten Small Caps
Global Report · Hong Kong's Forgotten Stocks Find New Life Through Bailouts and Breakthroughs
